Immix Biopharma (IMMX) EBIT (2021 - 2026)
Immix Biopharma's (IMMX) quarterly EBIT came in at -$10.8 million in Q1 2026, down 130.71% year-on-year from $35.2 million in Q1 2025, and up 0.82% quarter-over-quarter from -$10.9 million in Q4 2025.
Immix Biopharma (IMMX) EBIT (2021 - 2026) Analysis & Trends
Immix Biopharma has disclosed EBIT across 6 years of filings, most recently posting -$10.8 million for Q1 2026.
- EBIT for Q1 2026 came in at -$10.8 million, down 130.71% year-over-year; the trailing twelve-month figure through Mar 2026 was -$36.1 million (down 65.74% YoY), and the FY2025 annual result was -$30.0 million, down 32.11% from the prior year.
- EBIT came in at -$10.8 million for Q1 2026 at Immix Biopharma, up from -$10.9 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $6.5 million in Q4 2023 to a low of -$10.9 million in Q4 2025.
- The 5-year median for EBIT is -$4.7 million (2025), against an average of -$4.5 million.
- Across the five-year window, EBIT tumbled 718.38% in 2022 and surged 270.15% in 2023, its largest moves.
- Immix Biopharma's EBIT stood at -$3.8 million in 2022, then soared by 270.15% to $6.5 million in 2023, then tumbled by 177.24% to -$5.0 million in 2024, then tumbled by 118.43% to -$10.9 million in 2025, then climbed by 0.82% to -$10.8 million in 2026.
- The last three EBIT figures came in at -$10.8 million (Q1 2026), -$10.9 million (Q4 2025), and -$7.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -65.83 Mn |
| 10 | Immix Biopharma | 467.59 Mn | 467.59 Mn | - | -10.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.80 Mn |
| Dec 31, 2025 | -10.89 Mn |
| Sep 30, 2025 | -7.66 Mn |
| Jun 30, 2025 | -6.72 Mn |
| Mar 31, 2025 | -4.68 Mn |
| Dec 31, 2024 | -4.99 Mn |
| Sep 30, 2024 | -7.39 Mn |
| Jun 30, 2024 | -4.70 Mn |
| Mar 31, 2024 | -5.59 Mn |
| Dec 31, 2023 | 6.46 Mn |
| Sep 30, 2023 | -4.52 Mn |
| Jun 30, 2023 | -3.72 Mn |
| Mar 31, 2023 | -2.52 Mn |
| Dec 31, 2022 | -3.79 Mn |
| Sep 30, 2022 | -1.53 Mn |
| Jun 30, 2022 | -1.56 Mn |
| Mar 31, 2022 | -1.33 Mn |
| Dec 31, 2021 | -598,338.00 |
| Sep 30, 2021 | -347,991.00 |
| Jun 30, 2021 | -243,165.00 |